Tobias Loddenkemper |Medical Services
Specialities
部门
Programs
Languages
- 英语
- French
- German
Tobias Loddenkemper |Education
Medical School
Westfalische Wilhelms-Universitat
1999, Munster, Germany
Internship
Pediatrics
克利夫兰诊所
2004, Cleveland, OH
居住
Neurology
Westfalische Wilhelms-Universitat
德国芒斯特
居住
Pediatrics
克利夫兰诊所
Cleveland, OH
居住
Child Neurology
克利夫兰诊所
2008, Cleveland, OH
奖学金
Epilepsy & Clinical Neurophysiology
克利夫兰诊所
2003, Cleveland, OH
Tobias Loddenkemper |专业历史
As a pediatrician, pediatric neurologist, and clinical neurophysiologist, with specific training in seizure monitoring and treatment, I spend approximately 40% of my time in investigation, 20% in direct clinical care, 10% in teaching activities, and 30% in significant supporting activities. My early research experience as a resident and fellow included observational and interventional studies on clinical seizure manifestations and treatment. Following my 2008 appointment as Assistant in Neurology at Boston Children’s Hospital, I expanded my research to include circadian variation of seizures and used this information to develop a patient-oriented medication treatment schedule. My research is focused on identifying the factors that determine epileptic encephalopathies and status epilepticus as well as functional outcome later in life. Repetitive seizures and epileptic encephalopathy can impair development, plasticity and cognitive function of eloquent areas including language and memory. Seizure frequency reduction and seizure freedom, in particular after epilepsy surgery, have been shown to improve neurocognitive and developmental outcome. By identifying biomarkers that indicate predictors of cerebral damage and developmental outcome in epileptic encephalopathies and status epilepticus, we intend to reduce the occurrence of brain damage and later developmental disabilities and aim to identify novel therapeutic approaches.
What are we doing?
- Comparative effectiveness and interventional clinical trials in pediatric status epilepticus and epileptic encephalopathies
How do we do it?
-Inventing, evaluating and implementing clinically relevant biomarkers and treatment paradigmsto assess and benchmark these based on clinical data, neurophysiology, imaging, pharmacogenomics and genetics, in collaboration with basic researcher locally, nationally, and internationally.
-Developing and evaluating monitoring tools临床生物标志物,以进一步的临床癫痫结局指标,包括癫痫发作表征,神经心理学结局评估以及通过癫痫发作传感器和电子工具的方式评估,包括ICISS,包括RENCI癫痫发作跟踪和结果预测软件,以及新颖的现有和治疗疗法的监测软件设备和算法以及神经生理学,生化和遗传周期性标记,并将这些技术实施到临床工作流程中。
-Research networks and collaborationsare essential for our work, like the pediatric status epilepticus research group (www.pserg.org), the Pediatric Epilepsy Research Consortium , the pediatric critical care epilepsy research group, the Critical Care EEG consortium, the pediatric neurocritical care research group and other consortia.